{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T17:15:28Z","timestamp":1722618928823},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00347-013-2984-x","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T05:33:12Z","timestamp":1407130392000},"page":"733-739","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Uveitis bei multipler Sklerose"],"prefix":"10.1007","volume":"111","author":[{"given":"A.L.","family":"Hildebrandt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mackensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,6]]},"reference":[{"key":"2984_CR1","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1167\/iovs.05-1242","volume":"47","author":"Adamus","year":"2006","unstructured":"Adamus G, Burrows GG, Vandenbark AA et al (2006) Treatment of autoimmune anterior uveitis with recombinant TCR ligands. Invest Ophthalmol Vis Sci 47:2555\u20132561","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2984_CR2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0161-6420(84)34296-8","volume":"91","author":"Arnold","year":"1984","unstructured":"Arnold AC, Pepose JS, Hepler RS et al (1984) Retinal periphlebitis and retinitis in multiple sclerosis. I. Pathologic characteristics. Ophthalmology 91:255\u2013262","journal-title":"Ophthalmology"},{"key":"2984_CR3","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.2.292","volume":"121","author":"Beck","year":"2003","unstructured":"Beck RW, Trobe JD, Moke PS et al (2003) High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 121:944\u2013949","journal-title":"Arch Ophthalmol"},{"key":"2984_CR4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00115-007-2297-x","volume":"78","author":"Beyer","year":"2007","unstructured":"Beyer AM, Rosche B, Pleyer U et al (2007) The role of uveitis in demyelinating diseases of the central nervous system. Nervenarzt 78:1389\u20131398","journal-title":"Nervenarzt"},{"key":"2984_CR5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.52.1.179","volume":"52","author":"Biousse","year":"1999","unstructured":"Biousse V, Trichet C, Bloch-Michel E et al (1999) Multiple sclerosis associated with uveitis in two large clinic-based series. Neurology 52:179\u2013181","journal-title":"Neurology"},{"key":"2984_CR6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","volume":"362","author":"Cohen","year":"2010","unstructured":"Cohen JA, Barkhof F, Comi G et al (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362:402\u2013415","journal-title":"N Engl J Med"},{"key":"2984_CR7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ajo.2007.08.023","volume":"144","author":"Donaldson","year":"2007","unstructured":"Donaldson MJ, Pulido JS, Herman DC et al (2007) Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol 144:812\u2013817","journal-title":"Am J Ophthalmol"},{"key":"2984_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2004.04.016","volume":"223","author":"Fernandez","year":"2004","unstructured":"Fernandez O, Fernandez V, De Ramon E (2004) Azathioprine and methotrexate in multiple sclerosis. J Neurol Sci 223:29\u201334","journal-title":"J Neurol Sci"},{"key":"2984_CR9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000076892","volume":"36","author":"Gorczyca","year":"2004","unstructured":"Gorczyca WA, Ejma M, Witkowska D et al (2004) Retinal antigens are recognized by antibodies present in sera of patients with multiple sclerosis. Ophthalmic Res 36:120\u2013123","journal-title":"Ophthalmic Res"},{"key":"2984_CR10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","volume":"111","author":"Gritz","year":"2004","unstructured":"Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 111:491\u2013500","journal-title":"Ophthalmology"},{"key":"2984_CR11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/archopht.125.4.569","volume":"125","author":"Heinz","year":"2007","unstructured":"Heinz C, Heiligenhaus A (2007) Improvement of noninfectious uveitis with fumaric acid esters: results of a pilot study. Arch Ophthalmol 125:569\u2013571","journal-title":"Arch Ophthalmol"},{"key":"2984_CR12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","volume":"130","author":"Jabs","year":"2000","unstructured":"Jabs DA, Rosenbaum JT, Foster CS et al (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130:492\u2013513","journal-title":"Am J Ophthalmol"},{"key":"2984_CR13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/WNL.0b013e318248deea","volume":"78","author":"Jain","year":"2012","unstructured":"Jain N, Bhatti MT (2012) Fingolimod-associated macular edema: incidence, detection, and management. Neurology 78:672\u2013680","journal-title":"Neurology"},{"key":"2984_CR14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3899\/jrheum.080102","volume":"36","author":"Jakob","year":"2009","unstructured":"Jakob E, Reuland MS, Mackensen F et al (2009) Uveitis subtypes in a german interdisciplinary uveitis center \u2013 analysis of 1916 patients. J Rheumatol 36:127\u2013136","journal-title":"J Rheumatol"},{"key":"2984_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00006982-199010000-00008","volume":"10","author":"Kalina","year":"1990","unstructured":"Kalina PH, Pach JM, Buettner H et al (1990) Neovascularization of the disc in pars planitis. Retina 10:269\u2013273","journal-title":"Retina"},{"key":"2984_CR16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa052643","volume":"355","author":"Kappos","year":"2006","unstructured":"Kappos L, Antel J, Comi G et al (2006) Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 355:1124\u20131140","journal-title":"N Engl J Med"},{"key":"2984_CR17","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ajo.2008.06.004","volume":"146","author":"Kempen","year":"2008","unstructured":"Kempen JH, Ganesh SK, Sangwan VS et al (2008) Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis. Am J Ophthalmol 146:813\u2013818 e811","journal-title":"Am J Ophthalmol"},{"key":"2984_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/exer.1999.0777","volume":"70","author":"Kurose","year":"2000","unstructured":"Kurose S, Ikeda E, Tokiwa M et al (2000) Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats. Exp Eye Res 70:7\u201315","journal-title":"Exp Eye Res"},{"key":"2984_CR19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ajo.2013.05.002","volume":"156","author":"Mackensen","year":"2013","unstructured":"Mackensen F, Jakob E, Springer C et al (2013) Interferon versus methotrexate in intermediate uveitis with macular edema: results of a randomized controlled clinical trial. Am J Ophthalmol 156:478\u2013486 e471","journal-title":"Am J Ophthalmol"},{"key":"2984_CR20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0161-6420(93)31567-8","volume":"100","author":"Malinowski","year":"1993","unstructured":"Malinowski SM, Pulido JS, Folk JC (1993) Long-term visual outcome and complications associated with pars planitis. Ophthalmology 100:818\u2013824","journal-title":"Ophthalmology"},{"key":"2984_CR21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0161-6420(93)31505-8","volume":"100","author":"Malinowski","year":"1993","unstructured":"Malinowski SM, Pulido JS, Goeken NE et al (1993) The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology 100:1199\u20131205","journal-title":"Ophthalmology"},{"key":"2984_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jnnp-2013-305298","volume":"85","author":"Michel","year":"2013","unstructured":"Michel L, Vukusic S, De Seze J et al (2013) Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients. J Neurol Neurosurg Psychiatry 85:279\u2013283","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2984_CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4137\/JCNSD.S6692","volume":"4","author":"Nicholas","year":"2012","unstructured":"Nicholas J, Morgan-Followell B, Pitt D et al (2012) New and emerging disease-modifying therapies for relapsing-remitting multiple sclerosis: what is new and what is to come. J Cent Nerv Syst Dis 4:81\u2013103","journal-title":"J Cent Nerv Syst Dis"},{"key":"2984_CR24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","volume":"92","author":"Nussenblatt","year":"1985","unstructured":"Nussenblatt RB, Palestine AG, Chan CC et al (1985) Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92:467\u2013471","journal-title":"Ophthalmology"},{"key":"2984_CR25","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ophtha.2004.12.034","volume":"112","author":"Nussenblatt","year":"2005","unstructured":"Nussenblatt RB, Peterson JS, Foster CS et al (2005) Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. Ophthalmology 112:764\u2013770","journal-title":"Ophthalmology"},{"key":"2984_CR26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40263-013-0080-z","volume":"27","author":"Oh","year":"2013","unstructured":"Oh J, O\u2019Connor PW (2013) Safety, tolerability, and efficacy of oral therapies for relapsing-remitting multiple sclerosis. CNS Drugs 27:591\u2013609","journal-title":"CNS Drugs"},{"key":"2984_CR27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1076\/ocii.6.4.215.4024","volume":"6","author":"Okada","year":"1998","unstructured":"Okada AA, Keino H, Fukai T et al (1998) Effect of type I interferon on experimental autoimmune uveoretinitis in rats. Ocul Immunol Inflamm 6:215\u2013226","journal-title":"Ocul Immunol Inflamm"},{"key":"2984_CR28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1212\/WNL.0b013e3182a3525e","volume":"81","author":"Ortiz-Perez","year":"2013","unstructured":"Ortiz-Perez S, Martinez-Lapiscina EH, Gabilondo I et al (2013) Retinal periphlebitis is associated with multiple sclerosis severity. Neurology 81:877\u2013881","journal-title":"Neurology"},{"key":"2984_CR29","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0161-6420(99)90122-7","volume":"106","author":"Raja","year":"1999","unstructured":"Raja SC, Jabs DA, Dunn JP et al (1999) Pars planitis: clinical features and class II HLA associations. Ophthalmology 106:594\u2013599","journal-title":"Ophthalmology"},{"key":"2984_CR30","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/archopht.126.10.1390","volume":"126","author":"Raveney","year":"2008","unstructured":"Raveney BJ, Copland DA, Nicholson LB et al (2008) Fingolimod (FTY720) as an acute rescue therapy for intraocular inflammatory disease. Arch Ophthalmol 126:1390\u20131395","journal-title":"Arch Ophthalmol"},{"key":"2984_CR31","first-page":"335","volume":"47","author":"Rucker","year":"1972","unstructured":"Rucker CW (1972) Sheathing of the retinal veins in multiple sclerosis. Review of pertinent literature. Mayo Clin Proc 47:335\u2013340","journal-title":"Mayo Clin Proc"},{"key":"2984_CR32","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1212\/01.wnl.0000260612.51849.ed","volume":"68","author":"Sepulcre","year":"2007","unstructured":"Sepulcre J, Murie-Fernandez M, Salinas-Alaman A et al (2007) Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 68:1488\u20131494","journal-title":"Neurology"},{"key":"2984_CR33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","volume":"59","author":"Thacker","year":"2006","unstructured":"Thacker EL, Mirzaei F, Ascherio A (2006) Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 59:499\u2013503","journal-title":"Ann Neurol"},{"key":"2984_CR34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/09273940601147737","volume":"15","author":"Valentincic","year":"2007","unstructured":"Valentincic NV, Kraut A, Rothova A (2007) Vitreous hemorrhage in multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 15:19\u201325","journal-title":"Ocul Immunol Inflamm"},{"key":"2984_CR35","first-page":"31","volume":"11","author":"Younge","year":"1976","unstructured":"Younge BR (1976) Fluorescein angiography and retinal venous sheathing in multiple sclerosis. Can J Ophthalmol 11:31\u201336","journal-title":"Can J Ophthalmol"},{"key":"2984_CR36","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ophtha.2012.12.040","volume":"120","author":"Zarbin","year":"2013","unstructured":"Zarbin MA, Jampol LM, Jager RD et al (2013) Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis. Ophthalmology 120:1432\u20131439","journal-title":"Ophthalmology"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-013-2984-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-013-2984-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-013-2984-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T10:33:27Z","timestamp":1565692407000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-013-2984-x"}},"subtitle":["\u00dcbersicht und Ausblick"],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2984"],"URL":"https:\/\/doi.org\/10.1007\/s00347-013-2984-x","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}